A Novel Prodrug Strategy to Treat Prostate Cancer by Targeting MYC-Driven Nucleotide Biosynthesis
Abstract
Over the research period, a significant synthesis effort was underway to access proposed synthetic analogs of ribose-5-phosphate. The effort included execution of the two proposed synthetic approaches, which did not yield positive results and a design and execution of a new promising approach, which did yield one of the proposed analogs.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jun 01, 2018
- Accession Number
- AD1060304
Entities
People
- Matthew Parker
Organizations
- University of California